Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли Kevin F Mclaughlin. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что Kevin F Mclaughlin сообщил о владениях или сделках со следующими компаниями:
Безопасность | Заголовок | Последние зарегистрированные холдинги |
---|---|---|
US:VCEL / Vericel Corporation | Director | 15 100 |
US:DBTX / Decibel Therapeutics Inc | Director | 0 |
US:XLRN / Acceleron Pharma Inc | SVP, CFO and Treasurer | 0 |
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной Kevin F Mclaughlin. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
Инсайдерские покупки VCEL / Vericel Corporation – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в VCEL / Vericel Corporation. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
---|---|---|---|---|---|---|---|
Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи VCEL / Vericel Corporation – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в VCEL / Vericel Corporation. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Мин |
Цена в Мин |
Макс. потеря Избегается ($) |
Макс. потеря Избегается (%) |
---|---|---|---|---|---|---|---|
Для этой комбинации инсайдерской информации и ценных бумаг неизвестны незапланированные сделки на открытом рынке. |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных Kevin F Mclaughlin, раскрытый Комиссии по ценным бумагам и биржам (SEC).
Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 15 100 | -31,67 | 35,92 | -251 440 | 542 392 |
2025-08-08 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 15 100 | -31,67 | 39,98 | -279 860 | 603 698 |
2025-05-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 22 100 | 46,36 | 2,76 | 19 320 | 60 996 | |
2025-05-02 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 15 100 | 26,89 | ||||
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -1 000 | 11 900 | -7,75 | 55,43 | -55 430 | 659 617 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 000 | 12 900 | 8,40 | 2,76 | 2 760 | 35 604 | |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -6 000 | 11 900 | -33,52 | 55,47 | -332 820 | 660 093 |
2025-02-14 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 6 000 | 17 900 | 50,42 | 3,74 | 22 440 | 66 946 | |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -7 000 | 11 900 | -37,04 | 55,54 | -388 780 | 660 926 |
2024-11-15 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 7 000 | 18 900 | 58,82 | 3,74 | 26 180 | 70 686 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -2 000 | 11 900 | -14,39 | 45,99 | -91 980 | 547 281 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 000 | 13 900 | 16,81 | 3,74 | 7 480 | 51 986 | |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
S - Sale | X | -5 000 | 11 900 | -29,59 | 45,92 | -229 600 | 546 448 |
2024-08-09 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 5 000 | 16 900 | 42,02 | 3,74 | 18 700 | 63 206 | |
2024-05-03 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 3 200 | 11 900 | 36,78 | ||||
2023-09-25 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
D - Sale to Issuer | -5 000 | 0 | -100,00 | ||||
2023-06-14 |
|
4 | DBTX |
Decibel Therapeutics, Inc.
Common Stock |
A - Award | 5 000 | 5 000 | |||||
2023-04-28 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 8 700 | 42,62 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -2 600 | 0 | -100,00 | ||||
2022-04-29 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 2 600 | 6 100 | 74,29 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -18 806 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -24 334 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -20 500 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -11 262 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
D - Sale to Issuer | -2 663 | 0 | -100,00 | ||||
2021-11-22 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
U - Other | -10 681 | 0 | -100,00 | ||||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -170 | 20 500 | -0,82 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 200 | 11 262 | -31,59 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 370 | 10 681 | -33,46 | 160,38 | -861 241 | 1 713 019 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 170 | 16 051 | 1,07 | 41,64 | 7 079 | 668 364 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 200 | 15 881 | 48,68 | 40,61 | 211 172 | 644 927 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 330 | 20 670 | -26,18 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -9 800 | 16 462 | -37,32 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 500 | 2 663 | -48,42 | |||
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -983 | 10 681 | -8,43 | 161,26 | -158 519 | 1 722 418 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -18 647 | 11 664 | -61,52 | 160,26 | -2 988 368 | 1 869 273 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 330 | 30 311 | 31,90 | 41,64 | 305 221 | 1 262 150 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 9 800 | 22 981 | 74,35 | 40,61 | 397 978 | 933 258 |
2021-09-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 500 | 13 181 | 23,41 | 30,17 | 75 425 | 397 671 |
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 2 600 | 2 600 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 6 500 | 6 500 | |||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -1 750 | 0 | -100,00 | ||||
2021-04-30 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 3 500 | 100,00 | ||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 18 806 | 18 806 | |||||
2021-02-02 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 868 | 10 681 | 83,74 | ||||
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 | 5 813 | -0,07 | 123,50 | -494 | 717 906 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -296 | 5 817 | -4,84 | 122,85 | -36 364 | 714 618 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -499 | 6 113 | -7,55 | 121,89 | -60 823 | 745 114 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -700 | 6 612 | -9,57 | 120,43 | -84 301 | 796 283 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 7 312 | -3,94 | 124,45 | -37 335 | 909 978 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -667 | 7 612 | -8,06 | 124,47 | -83 021 | 947 466 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -600 | 8 279 | -6,76 | 123,49 | -74 094 | 1 022 374 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 8 879 | -2,20 | 125,49 | -25 098 | 1 114 226 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -713 | 9 079 | -7,28 | 124,28 | -88 612 | 1 128 338 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 9 792 | -7,55 | 123,54 | -98 832 | 1 209 704 |
2021-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
F - Taxes | -624 | 10 592 | -5,56 | 124,31 | -77 569 | 1 316 692 | |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 590 | 26 262 | -8,98 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -24 986 | 5 163 | -82,88 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 700 | 0 | -100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 252 | 0 | -100,00 | |||
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -42 528 | 11 216 | -79,13 | 130,14 | -5 534 594 | 1 459 650 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 590 | 53 744 | 5,06 | 40,61 | 105 180 | 2 182 544 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 24 986 | 51 154 | 95,48 | 30,17 | 753 828 | 1 543 316 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 700 | 26 168 | 41,69 | 27,97 | 215 369 | 731 919 |
2020-12-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 252 | 18 468 | 64,66 | 41,20 | 298 782 | 760 882 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 100 | 7 252 | -29,95 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 100 | 11 216 | -21,65 | 125,00 | -387 500 | 1 402 000 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 100 | 14 316 | 27,64 | 41,20 | 127 720 | 589 819 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 28 852 | -0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 28 852 | -0,35 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -100 | 30 149 | -0,33 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -200 | 7 700 | -2,53 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 11 216 | -4,27 | 125,12 | -62 560 | 1 403 346 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 716 | 0,86 | 40,61 | 4 061 | 475 787 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 616 | 0,87 | 30,17 | 3 017 | 350 455 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 200 | 11 516 | 1,77 | 27,97 | 5 594 | 322 103 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 100 | 11 316 | 0,89 | 41,20 | 4 120 | 466 219 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 873 | 28 952 | -6,08 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 051 | 30 249 | -3,36 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -400 | 7 900 | -4,82 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -548 | 10 452 | -4,98 | |||
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 872 | 11 216 | -25,66 | 125,03 | -484 116 | 1 402 336 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 873 | 15 088 | 14,17 | 40,61 | 76 063 | 612 724 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 051 | 13 215 | 8,64 | 30,17 | 31 709 | 398 697 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 400 | 12 164 | 3,40 | 27,97 | 11 188 | 340 227 |
2020-12-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 548 | 11 764 | 4,89 | 41,20 | 22 578 | 484 677 |
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
M - Exercise | -1 750 | 0 | -100,00 | 14,56 | -25 480 | ||
2020-05-01 |
|
4 | VCEL |
Vericel Corp
Common Stock |
M - Exercise | 1 750 | 1 750 | |||||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -17 226 | 11 000 | -61,03 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -17 226 | 11 216 | -60,57 | 88,19 | -1 519 161 | 989 139 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 17 226 | 28 442 | 153,58 | 41,20 | 709 711 | 1 171 810 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 31 300 | -24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 31 300 | -24,21 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -12 774 | 28 226 | -31,16 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -4 000 | 0 | -100,00 | |||
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 703 | 11 216 | -24,82 | 87,50 | -324 012 | 981 400 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 921 | 14 919 | -28,41 | 86,79 | -513 884 | 1 294 820 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -15 410 | 20 840 | -42,51 | 85,80 | -1 322 178 | 1 788 072 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 803 | 36 250 | -9,49 | 84,89 | -322 837 | 3 077 262 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 037 | 40 053 | -11,17 | 83,68 | -421 496 | 3 351 635 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 900 | 45 090 | -6,04 | 82,83 | -240 207 | 3 734 805 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 47 990 | 26,32 | 30,17 | 301 700 | 1 447 858 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 37 990 | 35,73 | 27,97 | 279 700 | 1 062 580 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 774 | 27 990 | 83,95 | 41,20 | 526 289 | 1 153 188 |
2020-04-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 4 000 | 15 216 | 35,66 | 24,11 | 96 440 | 366 858 |
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 24 334 | 24 334 | |||||
2020-01-24 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 369 | 11 216 | 131,40 | ||||
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 566 | 4 847 | -24,42 | 52,52 | -82 246 | 254 564 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 300 | 6 413 | -26,40 | 52,49 | -120 727 | 336 618 |
2020-01-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 713 | 8 713 | -16,43 | 52,51 | -89 950 | 457 520 |
2019-12-17 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -11 853 | 10 426 | -53,20 | 50,28 | -595 969 | 524 219 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -173 | 22 279 | -0,77 | 45,75 | -7 915 | 1 019 264 |
2019-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -7 827 | 22 452 | -25,85 | 45,29 | -354 485 | 1 016 851 |
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Restricted Stock Unit |
A - Award | 1 750 | 1 750 | |||||
2019-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 13 125 | 13 125 | |||||
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 30 279 | -0,33 | 45,46 | -4 546 | 1 376 483 |
2019-04-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -11 900 | 30 379 | -28,15 | 44,61 | -530 859 | 1 355 207 |
2019-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -648 | 42 279 | -1,51 | 48,02 | -31 117 | 2 030 238 |
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 28 000 | 28 000 | |||||
2019-01-29 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 4 700 | 42 927 | 12,29 | ||||
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -97 | 38 227 | -0,25 | 44,06 | -4 274 | 1 684 282 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 717 | 38 324 | -4,29 | 43,33 | -74 398 | 1 660 579 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 186 | 40 041 | -5,18 | 42,56 | -93 036 | 1 704 145 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 42 227 | -0,71 | 43,20 | -12 960 | 1 824 206 |
2019-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 412 | 42 527 | -3,21 | 42,37 | -59 826 | 1 801 869 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -12 500 | 18 300 | -40,58 | |||
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 43 939 | -22,15 | 54,00 | -675 000 | 2 372 706 |
2018-08-31 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 12 500 | 56 439 | 28,45 | 27,97 | 349 625 | 1 578 599 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -25 000 | 4 000 | -86,21 | |||
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 43 939 | -22,15 | 49,00 | -612 500 | 2 153 011 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -12 500 | 56 439 | -18,13 | 47,00 | -587 500 | 2 652 633 |
2018-07-03 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 25 000 | 68 939 | 56,90 | 24,11 | 602 750 | 1 662 119 |
2018-05-03 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 43 939 | -1,79 | 39,00 | -31 200 | 1 713 621 |
2018-04-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 200 | 44 739 | -6,68 | 38,31 | -122 592 | 1 713 951 |
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 825 | 30 825 | |||||
2018-03-05 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 138 | 47 939 | 12,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 42 801 | -0,47 | 43,84 | -8 768 | 1 876 396 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -14 800 | 43 001 | -25,61 | 43,00 | -636 400 | 1 849 043 |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -6 250 | 0 | -100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -6 251 | 0 | -100,00 | ||||
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 250 | 57 801 | 12,12 | 5,28 | 33 000 | 305 189 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 6 251 | 51 551 | 13,80 | 3,88 | 24 254 | 200 018 | |
2018-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 000 | 45 300 | -8,11 | 42,42 | -169 680 | 1 921 626 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -210 | 49 300 | -0,42 | 39,85 | -8 368 | 1 964 605 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 49 510 | -2,56 | 39,17 | -50 921 | 1 939 307 |
2017-09-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -14 490 | 50 810 | -22,19 | 38,32 | -555 257 | 1 947 039 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -18 750 | 0 | -100,00 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 150 | 6 250 | -33,51 | |||
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -34 400 | 65 300 | -34,50 | 32,00 | -1 100 800 | 2 089 600 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 18 750 | 99 700 | 23,16 | 7,12 | 133 500 | 709 864 |
2017-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 150 | 80 950 | 4,05 | 5,28 | 16 632 | 427 416 |
2017-05-05 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 17 500 | 17 500 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 300 | 41 300 | |||||
2017-03-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 6 900 | 77 800 | 9,73 | ||||
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 70 900 | -1,80 | 27,63 | -35 919 | 1 958 967 |
2017-01-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -400 | 72 200 | -0,55 | 26,87 | -10 748 | 1 940 014 |
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -10 000 | 6 251 | -61,53 | ||||
2017-01-04 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 72 600 | 15,97 | 3,88 | 38 800 | 281 688 | |
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 16 251 | -23,53 | ||||
2016-07-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 62 600 | 8,68 | 3,88 | 19 400 | 242 888 | |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -15 300 | 9 400 | -61,94 | |||
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -25 300 | 57 600 | -30,52 | 34,66 | -876 898 | 1 996 416 |
2016-07-06 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 15 300 | 82 900 | 22,63 | 5,28 | 80 784 | 437 712 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -300 | 24 700 | -1,20 | |||
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -25 300 | 67 600 | -27,23 | 34,00 | -860 200 | 2 298 400 |
2016-05-25 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 300 | 92 900 | 0,32 | 5,28 | 1 584 | 490 512 |
2016-05-06 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 15 000 | 15 000 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 30 800 | 30 800 | |||||
2016-03-07 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 5 100 | 92 600 | 5,83 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -7 500 | 21 251 | -26,09 | ||||
2015-12-23 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 7 500 | 87 500 | 9,38 | 3,88 | 29 100 | 339 500 | |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 28 751 | -19,58 | |||
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 460 | 80 000 | -4,15 | 24,64 | -85 254 | 1 971 200 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 540 | 83 460 | -4,07 | 24,12 | -85 385 | 2 013 055 |
2015-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 87 000 | 8,75 | 3,88 | 27 160 | 337 560 |
2015-09-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
A - Award | 40 000 | 80 000 | 100,00 | ||||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 35 751 | -4,03 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 37 251 | -11,83 | |||
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -176 | 40 000 | -0,44 | 31,16 | -5 484 | 1 246 400 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -724 | 40 176 | -1,77 | 30,45 | -22 046 | 1 223 359 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -600 | 40 900 | -1,45 | 29,39 | -17 634 | 1 202 051 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 293 | 40 000 | -3,13 | 31,07 | -40 174 | 1 242 800 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 500 | 41 293 | -5,71 | 30,22 | -75 550 | 1 247 874 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 207 | 43 793 | -2,68 | 29,11 | -35 136 | 1 274 814 |
2015-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 42 251 | -3,43 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 43 751 | -10,26 | |||
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 40 000 | -3,61 | 28,54 | -42 810 | 1 141 600 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 41 500 | 3,75 | 3,88 | 5 820 | 161 020 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 40 000 | -0,25 | 29,23 | -2 923 | 1 169 200 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 40 100 | -10,89 | 28,51 | -139 699 | 1 143 251 |
2015-08-12 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 45 000 | 12,50 | 3,88 | 19 400 | 174 600 |
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 48 751 | -9,30 | ||||
2015-07-30 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 | |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 53 751 | -3,59 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 55 751 | -8,23 | |||
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -95 | 35 000 | -0,27 | 30,39 | -2 887 | 1 063 650 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 905 | 35 095 | -5,15 | 29,68 | -56 540 | 1 041 620 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 37 000 | 5,71 | 3,88 | 7 760 | 143 560 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -377 | 35 000 | -1,07 | 30,27 | -11 412 | 1 059 450 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 623 | 35 377 | -11,56 | 29,65 | -137 072 | 1 048 928 |
2015-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 40 000 | 14,29 | 3,88 | 19 400 | 155 200 |
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 60 751 | -7,60 | ||||
2015-06-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 | |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 65 751 | -2,23 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 67 251 | -6,92 | |||
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 30 000 | -0,66 | 32,96 | -6 592 | 988 800 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 30 200 | -4,13 | 32,37 | -42 081 | 977 574 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 31 500 | 5,00 | 3,88 | 5 820 | 122 220 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 30 000 | -0,33 | 32,97 | -3 297 | 989 100 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 30 100 | -14,00 | 32,49 | -159 201 | 977 949 |
2015-06-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 35 000 | 16,67 | 3,88 | 19 400 | 135 800 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -5 000 | 72 251 | -6,47 | ||||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -6 500 | 77 251 | -7,76 | |||
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 | |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 25 000 | -5,66 | 31,78 | -47 670 | 794 500 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 26 500 | -0,38 | 32,40 | -3 240 | 858 600 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 900 | 26 600 | -15,56 | 31,79 | -155 771 | 845 614 |
2015-05-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 500 | 31 500 | 26,00 | 3,88 | 25 220 | 122 220 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 83 751 | -5,63 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 88 751 | -2,20 | |||
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -500 | 25 000 | -1,96 | 35,50 | -17 750 | 887 500 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 500 | 25 500 | -15,00 | 34,80 | -156 600 | 887 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -250 | 25 000 | -0,99 | 35,52 | -8 880 | 888 000 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 750 | 25 250 | -6,48 | 34,82 | -60 935 | 879 205 |
2015-04-08 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-03-24 |
|
4 | VCEL |
Vericel Corp
Stock Option (right to buy) |
A - Award | 20 000 | 20 000 | |||||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 90 751 | -1,63 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 92 251 | -5,14 | |||
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 25 000 | -0,79 | 40,94 | -8 188 | 1 023 500 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 25 200 | -4,91 | 40,14 | -52 182 | 1 011 528 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -619 | 25 000 | -2,42 | 40,93 | -25 336 | 1 023 250 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 381 | 25 619 | -14,60 | 40,16 | -175 941 | 1 028 859 |
2015-03-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -1 500 | 97 251 | -1,52 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 98 751 | -4,82 | |||
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 500 | 25 000 | -5,66 | 36,65 | -54 975 | 916 250 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 1 500 | 26 500 | 6,00 | 3,88 | 5 820 | 102 820 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -400 | 25 000 | -1,57 | 37,11 | -14 844 | 927 750 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 600 | 25 400 | -15,33 | 36,60 | -168 360 | 929 640 |
2015-02-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -2 000 | 103 751 | -1,89 | |||
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -845 | 25 000 | -3,27 | 41,04 | -34 679 | 1 026 000 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 155 | 25 845 | -4,28 | 40,38 | -46 639 | 1 043 621 |
2015-01-13 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 2 000 | 27 000 | 8,00 | 3,88 | 7 760 | 104 760 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 41 000 | 41 000 | |||||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -5 000 | 105 751 | -4,51 | |||
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 300 | 25 000 | -14,68 | 39,59 | -170 237 | 989 750 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -700 | 29 300 | -2,33 | 38,67 | -27 069 | 1 133 031 |
2015-01-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 5 000 | 30 000 | 20,00 | 3,88 | 19 400 | 116 400 |
2015-01-07 | 3 | VCEL |
Vericel Corp
No securities are beneficially owned |
0 | ||||||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -15 000 | 110 751 | -11,93 | ||||
2014-12-19 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 15 000 | 25 000 | 150,00 | 3,88 | 58 200 | 97 000 | |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 125 751 | -7,37 | |||
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 10 000 | -0,99 | 47,64 | -4 764 | 476 400 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 10 100 | -1,94 | 46,76 | -9 352 | 472 276 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 10 300 | -2,83 | 45,79 | -13 737 | 471 637 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 600 | 10 600 | -13,11 | 44,84 | -71 744 | 475 304 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 100 | 12 200 | -8,27 | 44,21 | -48 631 | 539 362 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 300 | 13 300 | -8,90 | 42,86 | -55 718 | 570 038 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 14 600 | -1,35 | 41,18 | -8 236 | 601 228 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -200 | 14 800 | -1,33 | 39,52 | -7 904 | 584 896 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -196 | 15 000 | -1,29 | 47,23 | -9 257 | 708 450 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -300 | 15 196 | -1,94 | 46,39 | -13 917 | 704 942 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 000 | 15 496 | -6,06 | 45,17 | -45 170 | 699 954 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 759 | 16 496 | -9,64 | 44,34 | -77 994 | 731 433 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 344 | 18 255 | -6,86 | 42,96 | -57 738 | 784 235 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 19 599 | -0,51 | 41,14 | -4 114 | 806 303 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -201 | 19 699 | -1,01 | 40,34 | -8 108 | 794 658 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 19 900 | -0,50 | 38,52 | -3 852 | 766 548 |
2014-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 135 751 | -6,86 | |||
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 138 | 10 000 | -23,88 | 33,58 | -105 374 | 335 800 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 862 | 13 138 | -12,41 | 32,39 | -60 310 | 425 540 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 050 | 15 000 | -16,90 | 33,60 | -102 480 | 504 000 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 950 | 18 050 | -9,75 | 32,44 | -63 258 | 585 542 |
2014-11-14 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 20 000 | 100,00 | 3,88 | 38 800 | 77 600 |
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | -10 000 | 145 751 | -6,42 | ||||
2014-10-27 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | ||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -10 000 | 155 751 | -6,03 | |||
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -10 000 | 0 | -100,00 | 29,25 | -292 500 | |
2014-10-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 10 000 | 10 000 | 3,88 | 38 800 | 38 800 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -6 700 | 165 751 | -3,89 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -370 | 0 | -100,00 | 24,75 | -9 158 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 330 | 370 | -94,48 | 24,24 | -153 439 | 8 969 |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 6 700 | 6 700 | 3,88 | 25 996 | 25 996 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 300 | 172 451 | -1,88 | |||
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 300 | 0 | -100,00 | 24,90 | -82 170 | |
2014-09-10 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 300 | 3 300 | 3,88 | 12 804 | 12 804 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 175 751 | -3,83 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 182 751 | -1,62 | |||
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -7 000 | 0 | -100,00 | 29,79 | -208 530 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -3 000 | 0 | -100,00 | 29,76 | -89 280 | |
2014-08-15 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 185 751 | -3,63 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 192 751 | -1,53 | |||
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 800 | 0 | -100,00 | 32,59 | -58 662 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -5 200 | 1 800 | -74,29 | 31,42 | -163 384 | 56 556 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -800 | 0 | -100,00 | 32,56 | -26 048 | |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 200 | 800 | -73,33 | 31,40 | -69 080 | 25 120 |
2014-07-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -7 000 | 195 751 | -3,45 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to purchase Common Stock |
M - Exercise | X | -3 000 | 202 751 | -1,46 | |||
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -4 197 | 0 | -100,00 | 31,98 | -134 220 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 803 | 4 197 | -40,04 | 31,16 | -87 341 | 130 779 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 686 | 0 | -100,00 | 32,00 | -53 952 | |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -1 314 | 1 686 | -43,80 | 31,17 | -40 957 | 52 553 |
2014-06-11 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -7 000 | 205 751 | -3,29 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
M - Exercise | X | -3 000 | 212 751 | -1,39 | |||
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -286 | 0 | -100,00 | 32,17 | -9 201 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -6 714 | 286 | -95,91 | 31,49 | -211 424 | 9 006 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 7 000 | 7 000 | 3,88 | 27 160 | 27 160 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -100 | 0 | -100,00 | 32,27 | -3 227 | |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
S - Sale | X | -2 900 | 100 | -96,67 | 31,48 | -91 292 | 3 148 |
2014-05-21 |
|
4 | XLRN |
ACCELERON PHARMA INC
Common Stock |
M - Exercise | X | 3 000 | 3 000 | 3,88 | 11 640 | 11 640 | |
2013-12-09 |
|
4 | XLRN |
ACCELERON PHARMA INC
Option to Purchase Common Stock |
A - Award | 29 000 | 29 000 |